摘要
目的:比较西咪替丁、更昔洛韦及利巴韦林治疗小儿水痘的疗效及安全性。方法:90例水痘患儿随机分为三组,利巴韦林组30例用利巴韦林注射液10mg/(kg·d);更昔洛韦组30例用更昔洛韦注射液5 mg/(kg·d);西咪替丁组30例用西咪替丁注射液15 mg/(kg·d),三组均1次/d静脉滴注,疗程5d,其他治疗相同。结果:西咪替丁组总有效率86.67%,更昔洛韦组总有效率93.33%,利巴韦林组总有效率63.33%;西咪替丁组和更昔洛韦组症状、体征好转时间比较差异无统计学意义(P>0.05),与利巴韦林组比较差异有统计学意义(P<0.05或P<0.01)。结论:西咪替丁和更昔洛韦治疗小儿水痘疗效显著,短期使用安全性好。
Objective: To investigate the effect and safety of cimetidine, ganciclovir and ribavirin in the treatment of pediatric varicella. Methods: 90 patients with pediatric varicella were randomly divided into three groups. Cimetidine group were given cimetidine in dosage of 15 mg/(kg.d) ; ganciclovir group were presented ganciclovir 5 mg/(kg.d) and ribavirin group were given ribavirin 10 mg/( kg. d). Three groups were all treated one time per day for five days. Results: Cimetidine group had an efficiency of 86.67 %, ganciclovir group an efficiency of 93.33 % and ribavirin group an efficiency of 63.33 %. The clinic symptoms and signs in cimetidine group and ganciclovir group got better more quickly than those in fibavirin group (P 〈 0.05 & P 〈 0.01 ), but there was no difference between the former two groups (P 〉 0.05). Conclusions: Cimetidine and ganciclovir were of obvious effect and safety in the treatment of pediatric varicella.
出处
《儿科药学杂志》
CAS
2007年第5期18-20,共3页
Journal of Pediatric Pharmacy